期刊文献+

乳腺疾病中血管内皮生长因子的表达及其意义 被引量:5

EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN BREAST DISEASES AND ITS IMPLICATION
暂未订购
导出
摘要 目的 观察乳腺良恶性疾病中血管内皮生长因子 (VEGF)的表达状况以及与肿瘤大小、临床分期、血行转移、腋淋巴结转移等预后因素的关系。方法 用免疫组化LSAB法分析了 70例乳腺浸润性导管癌、30例良性乳腺病和7例癌旁组织中VEGF的蛋白表达情况。结果 乳癌组和癌旁组VEGF表达水平显著高于良性病组。有血行转移或淋巴结转移组VEGF表达水平高于无转移组 ,而在其他预后因素中分布无差异。结论 VEGF表达水平对判定乳腺疾病良恶性及乳癌血行转移或淋巴转移的可能性有一定的预示价值。 Objective To evaluate the status of vascular endothelial growth factor (VEGF) expression in breast carcinoma and benign disease and define the relationship with age,menopause, tumor size,clinical stage,distant metastasis and lymph node metastasis. Methods Seventy cases of invasive ductal breast carcinomas,30 benign breast diseases and 7 adjacent non neoplastic specimens were assessed for VEGF protein expression by immunohistochemistry LSAB method. Results VEGF were expressed more frequently in breast cancer than in benign diseases.VEGF was significantly correlated with axillary lymph node metastasis and distant metastasis,whereas no statistical correlation with other factors. Conclusion VEGF status has certain value to make differential diagnosis between malignant and benign breast diseases and predict the possibilities of distant and lymph node metastasis.
出处 《中国普外基础与临床杂志》 CAS 2001年第5期322-323,共2页 Chinese Journal of Bases and Clinics In General Surgery
关键词 乳腺癌 血管内皮生长因子 血管生成 VEGF Breast carcinoma Vascular endothelial growth factor Angiogenesis
  • 相关文献

参考文献7

  • 1[1]Lichtenbeld HC,Barendsz JAF,Van EN.Angigenic potential of malignant and non-malignant human breast tissues an in vivo angiogenesis model [J]. Int J Cancer,1998; 77(4) ∶ 445
  • 2[2]Gruinelbretieve JM,Monique G,Gavoille A,et al.angiogenesis and risk of breast cancer in women with fibrocystic disease [J]. J Natl Cancer Inst,1994; 86(8) ∶ 635
  • 3[3]Grurid AJ,Fisher L,Harris JR.Microvessel density and distribution in ductal carcinoma in situ of the breast [J]. J Natl Cancer Inst,1994; 86(8) ∶ 614
  • 4[4]Jensen HM,Chen L,Devault MR.Angiogenesis induced by normal human breast tissue.A probable marker for precancer [J]. Science,1982; 218(4569) ∶ 293
  • 5[5]Wang G,Dong Z,Xu G,et al.The effect of antibody against vascular endothelial growth factor on tumor growth and metastasis [J]. J Cancer Res Clin Oncol,1998; 124(11) ∶ 615
  • 6[6]Brown L,Berse B,Jackman R.Expression of VPF/VEGF and its receptor in breast cancer [J]. Hum Pathol,1995; 26(1) ∶ 86
  • 7[7]Kurebayashi J, Otsuki T, Kumisue H. Expression of vascular endothelial growth factor (VEGF) family members in breast cancer [J]. Jpn J Cancer Res,1999; 90(9) ∶ 977

同被引文献52

  • 1王天宝,董文广,韩方海,李兆亭.血管内皮生长因子受体-3与胃癌临床病理因素的关系[J].中国普外基础与临床杂志,2004,11(4):341-343. 被引量:5
  • 2Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol, 1995; 147(1):9.
  • 3Fan ZN, Isobe K, Kiuchi K oet al. Enhancement of nitric oxide production from activated macrophages by a purified form of ginsenoside (Rg1). Am J Chin Med, 1995; 23(3-4) :279.
  • 4Imamura F, Horai T, Mukai M, et al. Serum requirement for in vitro invasion by tumor cells. Jpn J Cancer Res, 1991; 82(5):493.
  • 5Folkman J. Clinical application of research on angiogenesis.New Engl J Med, 1995; 333(26):1757.
  • 6Thompson WD, William WL, Maragoudakis M, et al. The clinical manipulation of angiogenesis: pathology, slde-effects,surprise and opportunities with novel human therapies. J Pathol, 2000; 190(3) :330.
  • 7Gasparini G, Harris A. Clinical importance of the determination of tumor angiogenesis in breast carcinoma ; much more than a new prognostic tool. J Clin Oncol, 1995; 139(3) :765.
  • 8O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastasis by a Lewis lung carcinoma. Cell, 1994; 79(2):315.
  • 9Slaton JW, Perotte P, Inoue K, et al. Interferon alpha mediated down regulation of angiogenesis related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule. Clin Cancer Res, 1999; 5 (10):2726.
  • 10Relf M, Lejeune S, Scott PA, et al. Expression of the angiogenic factors vascular endothelial cell growth factor,acidic and basic fibroblast growth factor,tumout growth bl,platlet-derived endothelial cell growth factor, placental growth factor and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res, 1997 ; 57(5) ; 963.

引证文献5

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部